The global CTMS Market is expected to reach 1,065.6 million by 2022 from USD 590.0 million in 2017, at a CAGR of 12.6%. The major factors driving the growth of the CTMS Market include the significant partnerships between Asian CROs and pharma companies, rising number of clinical trials in both developing and developed nations, availability of advanced and upgraded CTMS solutions, and rising government support for clinical trials in Asian countries.
- Advertising -
Access report at www.marketsandmarkets.com/Market-R…m_campaign=paidpr
The enterprise CTMS segment is estimated to account for the largest share of the CTMS Market by type in 2017
The CTMS Market is segmented into enterprise CTMS and site CTMS on the basis of type. The enterprise CTMS segment is expected to command the largest share of the global CTMS Market in 2017, and is expected to grow at the highest CAGR in the forecast period.
This is attributed to the widespread adoption of enterprise CTMS by majority of the end users.
- Advertising -
The pharmaceutical and biopharmaceutical companies segment is expected to hold the largest share of the market in 2017
Make An Inquiry @ www.marketsandmarkets.com/Enquiry_…m_campaign=paidpr
By end user, the CTMS Market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, medical device companies, and others. The pharmaceutical and biopharmaceutical companies segment is further sub segmented into large pharmaceutical companies and mid-small pharmaceutical companies.
The pharmaceutical and biopharmaceutical companies segment is expected to account for the largest share of the CTMS Market in 2017. The largest share is attributed to the increasing adoption of CTMS software during drug clinical trials by pharmaceutical and biopharmaceutical companies.
“North America is expected to dominate the CTMS Market during the forecast period”
Geographically, the CTMS Market is segmented into North America, Europe, Asia Pacific, and the rest of the world. North America is expected to account for the largest share of the global CTMS Market during the forecast period (2017-2022).
Factors such as rising number of on-going clinical trials (especially in the US), presence of leading players from both demand and supply sides, and government funding for clinical research are contributing to the large share of the North American region.
The major players operating in the CTMS Market include Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), and IBM (US).
Access report @ www.marketsandmarkets.com/pdfdownl…m_campaign=paidpr
Category: Market Research Publishers and RetailersCompany profile: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...
For more information: